Heléne E. K. Sundelin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Heléne E. K. Sundelin has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Johnny Ludvigsson
Division of Pediatrics, Department of Biomedical and Clinical Sciences Linköping University Linköping Sweden
7 shared publications - Anna Walås
Division of Children's and Women's Health, Department of Biomedical and Clinical Sciences, Linköping University, Sweden
4 shared publications - Peter Bang
Crown Princess Victoria’s Child and Youth Hospital, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
4 shared publications - Jenny Bolk
Clinical Epidemiology Division, Department of Medicine Solna Karolinska Institutet Stockholm Sweden
3 shared publications Jonas F. Ludvigsson
3 shared publications- Jonas Söderling
Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
3 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Wiley in Epileptic Disorders
Identifying drug‐resistant epilepsy using Swedish National Patient Registry data
Background: Approximately 30% of individuals with epilepsy are drug‐resistant, suffering low quality of life and should be evaluated for other treatment modalities. Drug‐resistant epilepsy has no specific diagnostic code, making identification in national healthcare registers challenging and limiting epidemiological research based on register data. Methods: To define our cohort, we used 1320 individuals from the Swedish National Epilepsy Surgery Register (SNESUR) as index individuals. Each index individual was matched with up to 17 individuals with epilepsy of similar age and diagnosis year in the Swedish National Patient Register. After excluding all SNESUR individuals, the study cohort consisted of 21 393 individuals, a cohort broadly representative of the general epilepsy population. Data on diagnoses, procedures, healthcare contacts, and dispensed antiseizure medications were obtained from national registers. A distance‐based ranking algorithm was developed and validated against medical records. Three machine‐learning classifiers were then trained and tested using a proxy of the International League Against Epilepsy definition of drug‐resistant epilepsy. Results: The ranking algorithm showed high performance for identifying drug‐resistant epilepsy, with a positive predictive value (PPV) of 86.2% (95% CI: 0.81–0.90). Out of the three machine‐learning classifiers, Gradient Boosting Machine achieved the highest F1‐score of 0.762 (along with PPV = 0.781, sensitivity = 0.744, specificity = 0.820, area under the precision‐recall curve = 0.858). The most significant variables found were “total visits to outpatient clinic due to epilepsy,” “age of onset of epilepsy,” “total admissions due to epilepsy,” and “total days of admission due to epilepsy.” Conclusion: Both the ranking algorithm and machine‐learning approaches showed good performance in register‐based phenotyping of drug‐resistant epilepsy using routinely collected register data, supporting their use in epidemiologic research.
- 18 September 2026
- Published by Wiley in Epileptic Disorders
Open AccessIdentifying drug‐resistant epilepsy using Swedish National Patient Registry data
Background: Approximately 30% of individuals with epilepsy are drug‐resistant, suffering low quality of life and should be evaluated for other treatment modalities. Drug‐resistant epilepsy has no specific diagnostic code, making identification in national healthcare registers challenging and limiting epidemiological research based on register data. Methods: To define our cohort, we used 1320 individuals from the Swedish National Epilepsy Surgery Register (SNESUR) as index individuals. Each index individual was matched with up to 17 individuals with epilepsy of similar age and diagnosis year in the Swedish National Patient Register. After excluding all SNESUR individuals, the study cohort consisted of 21 393 individuals, a cohort broadly representative of the general epilepsy population. Data on diagnoses, procedures, healthcare contacts, and dispensed antiseizure medications were obtained from national registers. A distance‐based ranking algorithm was developed and validated against medical records. Three machine‐learning classifiers were then trained and tested using a proxy of the International League Against Epilepsy definition of drug‐resistant epilepsy. Results: The ranking algorithm showed high performance for identifying drug‐resistant epilepsy, with a positive predictive value (PPV) of 86.2% (95% CI: 0.81–0.90). Out of the three machine‐learning classifiers, Gradient Boosting Machine achieved the highest F1‐score of 0.762 (along with PPV = 0.781, sensitivity = 0.744, specificity = 0.820, area under the precision‐recall curve = 0.858). The most significant variables found were “total visits to outpatient clinic due to epilepsy,” “age of onset of epilepsy,” “total admissions due to epilepsy,” and “total days of admission due to epilepsy.” Conclusion: Both the ranking algorithm and machine‐learning approaches showed good performance in register‐based phenotyping of drug‐resistant epilepsy using routinely collected register data, supporting their use in epidemiologic research.
- Open Access
- 25 March 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (6) , e213333
Maternal Overweight and Obesity and Risk of Perinatal Ischemic Stroke
Overweight and obesity in pregnant women are a growing problem contributing to increased risks of obstetric and perinatal complications. However, the impact of maternal overweight and obesity on the risk of perinatal stroke in the infant remains unexplored. We aimed to evaluate the association between maternal early pregnancy body mass index (BMI) and risk of perinatal ischemic stroke. This nationwide cohort study includes singleton births in Sweden at ≥22 + 0 weeks without major congenital malformations, between January 1, 1998, and December 31, 2019, with a follow-up time of up to 28 days after birth. Data were obtained by individual record linkages of nationwide Swedish registers. Exposure was maternal BMI in early pregnancy. The outcome, perinatal ischemic stroke, was defined as a diagnosis of ischemic stroke at ≤28 days of age in the Medical Birth Register, the National Patient Register, or the Swedish Neonatal Quality Register. Multivariable Poisson log-linear regressions and spline regression were used to estimate adjusted rate ratios (aRRs) and 95% CIs. Among the 2,140,852 births, 415 infants (192 girls) were diagnosed with perinatal ischemic stroke. Rates of perinatal ischemic stroke increased from 19/100,000 in infants to normal-weight women (BMI 18.5 < 25 kg/m2) to 22/100,000 among infants to mothers with overweight (BMI 25 < 30 kg/m2), to 35/100,000 among infants to women with obesity class II (BMI 30 < 35 kg/m2), and to 40/100,000 among infants to women with obesity class III (BMI ≥35 kg/m2). The adjusted rate ratio of perinatal ischemic stroke increased almost linearly with increasing maternal BMI. When estimating risk per BMI class, aRRs of perinatal ischemic stroke were 1.16 (95% CI 0.91-1.46) for overweight, 1.82 (95% CI 1.34-2.44) for obesity class I, and 1.96 (95% CI 1.27-2.91) for obesity classes II-III, compared with infants of mothers with normal weight. The risk of perinatal ischemic stroke increased with increasing maternal BMI in a dose-response manner. The findings support maternal obesity as a potential risk factor of perinatal ischemic stroke. A limitation of this study was that although the perinatal ischemic stroke diagnosis has high predictive value in Swedish registers, we cannot rule out that cases might be underdetected.
- 25 March 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (6) , e213333
Open AccessMaternal Overweight and Obesity and Risk of Perinatal Ischemic Stroke
Overweight and obesity in pregnant women are a growing problem contributing to increased risks of obstetric and perinatal complications. However, the impact of maternal overweight and obesity on the risk of perinatal stroke in the infant remains unexplored. We aimed to evaluate the association between maternal early pregnancy body mass index (BMI) and risk of perinatal ischemic stroke. This nationwide cohort study includes singleton births in Sweden at ≥22 + 0 weeks without major congenital malformations, between January 1, 1998, and December 31, 2019, with a follow-up time of up to 28 days after birth. Data were obtained by individual record linkages of nationwide Swedish registers. Exposure was maternal BMI in early pregnancy. The outcome, perinatal ischemic stroke, was defined as a diagnosis of ischemic stroke at ≤28 days of age in the Medical Birth Register, the National Patient Register, or the Swedish Neonatal Quality Register. Multivariable Poisson log-linear regressions and spline regression were used to estimate adjusted rate ratios (aRRs) and 95% CIs. Among the 2,140,852 births, 415 infants (192 girls) were diagnosed with perinatal ischemic stroke. Rates of perinatal ischemic stroke increased from 19/100,000 in infants to normal-weight women (BMI 18.5 < 25 kg/m2) to 22/100,000 among infants to mothers with overweight (BMI 25 < 30 kg/m2), to 35/100,000 among infants to women with obesity class II (BMI 30 < 35 kg/m2), and to 40/100,000 among infants to women with obesity class III (BMI ≥35 kg/m2). The adjusted rate ratio of perinatal ischemic stroke increased almost linearly with increasing maternal BMI. When estimating risk per BMI class, aRRs of perinatal ischemic stroke were 1.16 (95% CI 0.91-1.46) for overweight, 1.82 (95% CI 1.34-2.44) for obesity class I, and 1.96 (95% CI 1.27-2.91) for obesity classes II-III, compared with infants of mothers with normal weight. The risk of perinatal ischemic stroke increased with increasing maternal BMI in a dose-response manner. The findings support maternal obesity as a potential risk factor of perinatal ischemic stroke. A limitation of this study was that although the perinatal ischemic stroke diagnosis has high predictive value in Swedish registers, we cannot rule out that cases might be underdetected.
- Open Access
- 22 May 2024
- Published by Springer Nature in BMC Pediatrics
- Vol. 24 (1) , 1-10
‘We did everything by phone’: a qualitative study of mothers' experience of smartphone-aided screening of cerebral palsy in Kathmandu, Nepal
Background: International guidelines recommend early intervention to all children at risk of cerebral palsy, but targeted screening programs are often lacking in low- and middle-income settings with the highest burden of disease. Smartphone applications have the potential to improve access to early diagnostics by empowering parents to film their children at home followed by centralized evaluation of videos with General Movements Assessment. We explored mothers’ perceptions about participating in a smartphone aided cerebral palsy screening program in Kathmandu, Nepal. Methods: This is an explorative qualitative study that used focus group discussions (n = 2) and individual interviews (n = 4) with mothers of term-born infants surviving birth asphyxia or neonatal seizures. Parents used the NeuroMotion™ smartphone app to film their children at home and the videos were analysed using Precthl’s General Movements Assessment. Sekhon et al.’s framework on the acceptability of health care interventions guided the design of the group discussions and interviews, and the deductive qualitative content analysis. Results: Mothers were interested in engaging with the programme and expressed hope it would benefit their children. Most felt using the app was intuitive. They were, however, unclear about the way the analysis was performed. Support from the research team was often needed to overcome an initial lack of self-confidence in using the technology, and to reduce anxiety related to the follow-up. The intervention was overall perceived as recommendable but should be supplemented by a face-to-face consultation. Conclusion: Smartphone aided remote screening of cerebral palsy is acceptable in a lower middle-income population but requires additional technical support.
- 22 May 2024
- Published by Springer Nature in BMC Pediatrics
- Vol. 24 (1) , 1-10
Open Access‘We did everything by phone’: a qualitative study of mothers' experience of smartphone-aided screening of cerebral palsy in Kathmandu, Nepal
Background: International guidelines recommend early intervention to all children at risk of cerebral palsy, but targeted screening programs are often lacking in low- and middle-income settings with the highest burden of disease. Smartphone applications have the potential to improve access to early diagnostics by empowering parents to film their children at home followed by centralized evaluation of videos with General Movements Assessment. We explored mothers’ perceptions about participating in a smartphone aided cerebral palsy screening program in Kathmandu, Nepal. Methods: This is an explorative qualitative study that used focus group discussions (n = 2) and individual interviews (n = 4) with mothers of term-born infants surviving birth asphyxia or neonatal seizures. Parents used the NeuroMotion™ smartphone app to film their children at home and the videos were analysed using Precthl’s General Movements Assessment. Sekhon et al.’s framework on the acceptability of health care interventions guided the design of the group discussions and interviews, and the deductive qualitative content analysis. Results: Mothers were interested in engaging with the programme and expressed hope it would benefit their children. Most felt using the app was intuitive. They were, however, unclear about the way the analysis was performed. Support from the research team was often needed to overcome an initial lack of self-confidence in using the technology, and to reduce anxiety related to the follow-up. The intervention was overall perceived as recommendable but should be supplemented by a face-to-face consultation. Conclusion: Smartphone aided remote screening of cerebral palsy is acceptable in a lower middle-income population but requires additional technical support.
- Open Access
- 10 May 2022
- Published by Wolters Kluwer Health in Neurology
- Vol. 98 (19) , e1953-e1963
Risk of Autism After Pediatric Ischemic Stroke
Background and Objectives Ischemic stroke increases the risk of neurodevelopmental disorders; however, the risk of autism is not thoroughly explored. Our aim was to evaluate risk of autism and risk factors for autism in children with pediatric ischemic stroke and in their first-degree relatives. Methods In this cohort study, individuals with ischemic stroke from 1969 to 2016, <18 years of age, alive 1 week after stroke, and without prior autism were identified in Swedish national registers. Ten matched controls per index individual and all first-degree relatives of index individuals and controls were identified. Conditional Cox regression was used to calculate the risk of autism. Unconditional logistic regression was performed to analyze sex, gestational age, age at stroke diagnoses, comorbid adverse motor outcome, comorbid epilepsy, and a sibling with autism as risk factors for autism in children with ischemic stroke. Results Of the 1,322 index individuals, 46 (3.5%) were diagnosed with autism compared to 161 (1.2%) controls (adjusted hazard ratio [aHR] 3.02, 95% CI 2.15–4.25). There was no significant difference in risk of autism according to age at stroke: perinatal (aHR 2.69, 95% CI 1.44–5.03) and childhood stroke (aHR 3.18, 95% CI 2.12–4.78). The increased risk remained after exclusion of children born preterm or small for gestational age (aHR 3.78, 95% CI 2.55–5.60) and when children with stroke diagnosed from 1997 to 2014 were analyzed (aHR 2.91, 95% CI = 1.95–4.35). Compared to controls, the risk of autism was increased in individuals with ischemic stroke and comorbid epilepsy (aHR 7.05, 95% CI 3.74–13.30), as well as adverse motor outcome (aHR 4.28, 95% CI 2.44–7.51). When individuals with adverse motor outcome and epilepsy were censored, the risk of autism was still increased (aHR 2.37, 95% CI 1.45–3.85). Sex, gestational age, and having a sibling with autism were not associated with autism in individuals with pediatric ischemic stroke. Discussion An increased risk of autism was seen after pediatric ischemic stroke, particularly in individuals with comorbid epilepsy, and could not be explained by being born preterm or small for gestational age. The risk was increased also in individuals free from epilepsy and adverse motor outcome, implying that all children with ischemic stroke should be readily screened for autism if the disorder is suspected.
- 10 May 2022
- Published by Wolters Kluwer Health in Neurology
- Vol. 98 (19) , e1953-e1963
Open AccessRisk of Autism After Pediatric Ischemic Stroke
Background and Objectives Ischemic stroke increases the risk of neurodevelopmental disorders; however, the risk of autism is not thoroughly explored. Our aim was to evaluate risk of autism and risk factors for autism in children with pediatric ischemic stroke and in their first-degree relatives. Methods In this cohort study, individuals with ischemic stroke from 1969 to 2016, <18 years of age, alive 1 week after stroke, and without prior autism were identified in Swedish national registers. Ten matched controls per index individual and all first-degree relatives of index individuals and controls were identified. Conditional Cox regression was used to calculate the risk of autism. Unconditional logistic regression was performed to analyze sex, gestational age, age at stroke diagnoses, comorbid adverse motor outcome, comorbid epilepsy, and a sibling with autism as risk factors for autism in children with ischemic stroke. Results Of the 1,322 index individuals, 46 (3.5%) were diagnosed with autism compared to 161 (1.2%) controls (adjusted hazard ratio [aHR] 3.02, 95% CI 2.15–4.25). There was no significant difference in risk of autism according to age at stroke: perinatal (aHR 2.69, 95% CI 1.44–5.03) and childhood stroke (aHR 3.18, 95% CI 2.12–4.78). The increased risk remained after exclusion of children born preterm or small for gestational age (aHR 3.78, 95% CI 2.55–5.60) and when children with stroke diagnosed from 1997 to 2014 were analyzed (aHR 2.91, 95% CI = 1.95–4.35). Compared to controls, the risk of autism was increased in individuals with ischemic stroke and comorbid epilepsy (aHR 7.05, 95% CI 3.74–13.30), as well as adverse motor outcome (aHR 4.28, 95% CI 2.44–7.51). When individuals with adverse motor outcome and epilepsy were censored, the risk of autism was still increased (aHR 2.37, 95% CI 1.45–3.85). Sex, gestational age, and having a sibling with autism were not associated with autism in individuals with pediatric ischemic stroke. Discussion An increased risk of autism was seen after pediatric ischemic stroke, particularly in individuals with comorbid epilepsy, and could not be explained by being born preterm or small for gestational age. The risk was increased also in individuals free from epilepsy and adverse motor outcome, implying that all children with ischemic stroke should be readily screened for autism if the disorder is suspected.
- 1 March 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (3) , 837-844
Long-Term Mortality in Children With Ischemic Stroke: A Nationwide Register-Based Cohort Study
Background and Purpose: Ischemic stroke is a common cause of death in adults, however, mortality after pediatric ischemic stroke is not well explored. We investigate long-term and cause-specific mortality in children with ischemic stroke and their first-degree relatives. Methods: Through nationwide Swedish registers, we identified 1606 individuals 28 days of age (HR=1.23 [95% CI, 1.06–1.42]) compared with the relatives of the controls. Conclusions: Long-term mortality increased after pediatric ischemic stroke, even 20 years later, with neurological diseases as the most frequent cause of death.
- 1 March 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (3) , 837-844
Long-Term Mortality in Children With Ischemic Stroke: A Nationwide Register-Based Cohort Study
Background and Purpose: Ischemic stroke is a common cause of death in adults, however, mortality after pediatric ischemic stroke is not well explored. We investigate long-term and cause-specific mortality in children with ischemic stroke and their first-degree relatives. Methods: Through nationwide Swedish registers, we identified 1606 individuals 28 days of age (HR=1.23 [95% CI, 1.06–1.42]) compared with the relatives of the controls. Conclusions: Long-term mortality increased after pediatric ischemic stroke, even 20 years later, with neurological diseases as the most frequent cause of death.
- Open Access
- 16 February 2022
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 36 (3) , 412-421
Adverse motor outcome after paediatric ischaemic stroke: A nationwide cohort study
Background Various frequencies of adverse motor outcomes (cerebral palsy and hemiplegia) after paediatric ischaemic stroke have been reported. Few reports on the risks of adverse motor outcomes in nationwide cohorts and contributing risk factors are available. Objectives To assess risk of adverse motor outcome and potential risk factors thereof after paediatric ischaemic stroke in a nationwide cohort. Methods This nationwide matched cohort study identified 877 children <18 years of age diagnosed with ischaemic stroke through the Swedish national health registers from 1997 to 2016. These children, exposed to ischaemic stroke, alive 1 week after stroke, were matched for age, sex and county of residence with 10 unexposed children. Using Cox regression, we estimated the risk of adverse motor outcomes in children with stroke compared to that in unexposed children. Logistic regression was applied to compare the characteristics of children with and without adverse motor outcomes after stroke. Results Out of the 877 children with ischaemic stroke, 280 (31.9%) suffered adverse motor outcomes compared with 21 (0.2%) of the 8770 unexposed: adjusted hazard ratio (aHR) 167.78 (95% confidence interval (CI) 107.58, 261.66). There were no differences between risk estimates of adverse motor outcome according to age at stroke: perinatal stroke (aHR 124.11, 95% CI 30.45, 505.84) and childhood stroke (aHR 182.37, 95% CI 113.65, 292.64). An association between adverse motor outcome and childhood stroke aOR 1.56 (95% CI 1.05, 2.31) was found when analysing only children with ischaemic stroke. No associations were found between adverse motor outcome and sex, gestational age or parental age at birth. Conclusions The risk of adverse motor outcome is substantial after paediatric ischaemic stroke, especially childhood stroke, confirming results of previous smaller studies. This study found no associations between sex, gestational age or parental age and adverse motor outcome after paediatric ischaemic stroke.
- 16 February 2022
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 36 (3) , 412-421
Open AccessAdverse motor outcome after paediatric ischaemic stroke: A nationwide cohort study
Background Various frequencies of adverse motor outcomes (cerebral palsy and hemiplegia) after paediatric ischaemic stroke have been reported. Few reports on the risks of adverse motor outcomes in nationwide cohorts and contributing risk factors are available. Objectives To assess risk of adverse motor outcome and potential risk factors thereof after paediatric ischaemic stroke in a nationwide cohort. Methods This nationwide matched cohort study identified 877 children <18 years of age diagnosed with ischaemic stroke through the Swedish national health registers from 1997 to 2016. These children, exposed to ischaemic stroke, alive 1 week after stroke, were matched for age, sex and county of residence with 10 unexposed children. Using Cox regression, we estimated the risk of adverse motor outcomes in children with stroke compared to that in unexposed children. Logistic regression was applied to compare the characteristics of children with and without adverse motor outcomes after stroke. Results Out of the 877 children with ischaemic stroke, 280 (31.9%) suffered adverse motor outcomes compared with 21 (0.2%) of the 8770 unexposed: adjusted hazard ratio (aHR) 167.78 (95% confidence interval (CI) 107.58, 261.66). There were no differences between risk estimates of adverse motor outcome according to age at stroke: perinatal stroke (aHR 124.11, 95% CI 30.45, 505.84) and childhood stroke (aHR 182.37, 95% CI 113.65, 292.64). An association between adverse motor outcome and childhood stroke aOR 1.56 (95% CI 1.05, 2.31) was found when analysing only children with ischaemic stroke. No associations were found between adverse motor outcome and sex, gestational age or parental age at birth. Conclusions The risk of adverse motor outcome is substantial after paediatric ischaemic stroke, especially childhood stroke, confirming results of previous smaller studies. This study found no associations between sex, gestational age or parental age and adverse motor outcome after paediatric ischaemic stroke.
- 1 November 2021
- Published by Wolters Kluwer Health in Stroke
- Vol. 52 (11) , 3532-3540
Pediatric Ischemic Stroke and Epilepsy: A Nationwide Cohort Study
Background and Purpose: The risk of epilepsy after stroke has not been thoroughly explored in pediatric ischemic stroke. We examined the risk of epilepsy in children with ischemic stroke as well as in their first-degree relatives. Methods: In Swedish National Registers, we identified 1220 children <18 years with pediatric ischemic stroke diagnosed 1969 to 2016, alive 7 days after stroke and with no prior epilepsy. We used 12 155 age- and sex-matched individuals as comparators. All first-degree relatives to index individuals and comparators were also identified. The risk of epilepsy was estimated in children with ischemic stroke and in their first-degree relatives using Cox proportional hazard regression model. Results: Through this nationwide population-based study, 219 (18.0%) children with ischemic stroke and 91 (0.7%) comparators were diagnosed with epilepsy during follow-up corresponding to a 27.8-fold increased risk of future epilepsy (95% CI, 21.5–36.0). The risk of epilepsy was still elevated after 20 years (hazard ratio [HR], 7.9 [95% CI, 3.3–19.0]), although the highest HR was seen in the first 6 months (HR, 119.4 [95% CI, 48.0–297.4]). The overall incidence rate of epilepsy was 27.0 per 100 000 person-years (95% CI, 21.1–32.8) after ischemic stroke diagnosed ≤day 28 after birth (perinatal) and 11.6 per 100 000 person-years (95% CI, 9.6–13.5) after ischemic stroke diagnosed ≥day 29 after birth (childhood). Siblings and parents, but not offspring, to children with ischemic stroke were at increased risk of epilepsy (siblings: HR, 1.64 [95% CI, 1.08–2.48] and parents: HR, 1.41 [95% CI, 1.01–1.98]). Conclusions: The risk of epilepsy after ischemic stroke in children is increased, especially after perinatal ischemic stroke. The risk of epilepsy was highest during the first 6 months but remained elevated even 20 years after stroke which should be taken into account in future planning for children affected by stroke.
- 1 November 2021
- Published by Wolters Kluwer Health in Stroke
- Vol. 52 (11) , 3532-3540
Pediatric Ischemic Stroke and Epilepsy: A Nationwide Cohort Study
Background and Purpose: The risk of epilepsy after stroke has not been thoroughly explored in pediatric ischemic stroke. We examined the risk of epilepsy in children with ischemic stroke as well as in their first-degree relatives. Methods: In Swedish National Registers, we identified 1220 children <18 years with pediatric ischemic stroke diagnosed 1969 to 2016, alive 7 days after stroke and with no prior epilepsy. We used 12 155 age- and sex-matched individuals as comparators. All first-degree relatives to index individuals and comparators were also identified. The risk of epilepsy was estimated in children with ischemic stroke and in their first-degree relatives using Cox proportional hazard regression model. Results: Through this nationwide population-based study, 219 (18.0%) children with ischemic stroke and 91 (0.7%) comparators were diagnosed with epilepsy during follow-up corresponding to a 27.8-fold increased risk of future epilepsy (95% CI, 21.5–36.0). The risk of epilepsy was still elevated after 20 years (hazard ratio [HR], 7.9 [95% CI, 3.3–19.0]), although the highest HR was seen in the first 6 months (HR, 119.4 [95% CI, 48.0–297.4]). The overall incidence rate of epilepsy was 27.0 per 100 000 person-years (95% CI, 21.1–32.8) after ischemic stroke diagnosed ≤day 28 after birth (perinatal) and 11.6 per 100 000 person-years (95% CI, 9.6–13.5) after ischemic stroke diagnosed ≥day 29 after birth (childhood). Siblings and parents, but not offspring, to children with ischemic stroke were at increased risk of epilepsy (siblings: HR, 1.64 [95% CI, 1.08–2.48] and parents: HR, 1.41 [95% CI, 1.01–1.98]). Conclusions: The risk of epilepsy after ischemic stroke in children is increased, especially after perinatal ischemic stroke. The risk of epilepsy was highest during the first 6 months but remained elevated even 20 years after stroke which should be taken into account in future planning for children affected by stroke.
- Open Access
- 4 February 2021
- Published by Wiley in Acta Paediatrica
- Vol. 110 (7) , 2179-2186
Paediatric ischaemic stroke is a valid diagnosis in the Swedish National Patient Register
Aim: The Swedish National Patient Register offers unique opportunities for epidemiological research of paediatric ischaemic stroke. We aimed to validate the diagnosis of paediatric ischaemic stroke in the National Patient Register to ensure the quality of future research.Methods: The PedStroke cohort consists of 1606 individuals aged <18 years with a diagnosis of paediatric ischaemic stroke (ICD‐10: I63, I64; ICD‐8 and 9: 433, 434, 436) in Swedish national health registers between 1969 and 2016. We selected 292 cases for validation by reviewing medical charts.Results: In all, 277 of the 292 medical charts were received, of which 273 had enough information to qualify for review. The diagnosis was correct in 242/273 cases, yielding a positive predictive value (PPV) of 89% (95% confidence interval (CI): 0.85–0.92) for paediatric ischaemic stroke in the National Patient Register. After validation, seven cases of 222 with childhood stroke were re‐categorised to perinatal stroke, resulting in a total of 56 perinatal stroke cases. In the Medical Birth Register, 38 stroke cases were identified of which 37 had correct diagnosis, generating a PPV of 97% (95% CI: 0.92–1.0). Incorrect diagnoses decreased over time and the number of diagnoses confirmed by radiology increased correspondingly.Conclusion: The National Patient Register is reliable for epidemiological research of paediatric ischaemic stroke because of its high PPV for this diagnosis.
- 4 February 2021
- Published by Wiley in Acta Paediatrica
- Vol. 110 (7) , 2179-2186
Open AccessPaediatric ischaemic stroke is a valid diagnosis in the Swedish National Patient Register
Aim: The Swedish National Patient Register offers unique opportunities for epidemiological research of paediatric ischaemic stroke. We aimed to validate the diagnosis of paediatric ischaemic stroke in the National Patient Register to ensure the quality of future research.Methods: The PedStroke cohort consists of 1606 individuals aged <18 years with a diagnosis of paediatric ischaemic stroke (ICD‐10: I63, I64; ICD‐8 and 9: 433, 434, 436) in Swedish national health registers between 1969 and 2016. We selected 292 cases for validation by reviewing medical charts.Results: In all, 277 of the 292 medical charts were received, of which 273 had enough information to qualify for review. The diagnosis was correct in 242/273 cases, yielding a positive predictive value (PPV) of 89% (95% confidence interval (CI): 0.85–0.92) for paediatric ischaemic stroke in the National Patient Register. After validation, seven cases of 222 with childhood stroke were re‐categorised to perinatal stroke, resulting in a total of 56 perinatal stroke cases. In the Medical Birth Register, 38 stroke cases were identified of which 37 had correct diagnosis, generating a PPV of 97% (95% CI: 0.92–1.0). Incorrect diagnoses decreased over time and the number of diagnoses confirmed by radiology increased correspondingly.Conclusion: The National Patient Register is reliable for epidemiological research of paediatric ischaemic stroke because of its high PPV for this diagnosis.
- 18 November 2019
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 99 (4) , 518-524
Pregnancy outcome in women with cerebral palsy: A nationwide population‐based cohort study
Introduction: Cerebral palsy (CP) is a lifelong disorder with a high rate of comorbidities and complications. We hypothesized that women with CP are at increased risk of adverse pregnancy outcome.Material and methods: In this nationwide population‐based cohort study 1997‐2011, we examined the outcome of 770 births in women with CP vs 1 247 408 births in women without a CP diagnosis using the Swedish Medical Birth Register. We used unconditional logistic regression, adjusting for maternal age, smoking, parity, year of birth and epilepsy, to calculate adjusted odds ratios for adverse pregnancy outcome. Main adverse outcome was preterm birth. Secondary outcomes were cesarean section, induction of labor, low 5‐min Apgar score, small for gestational age, large for gestational age, and stillbirth.Results: After adjusting for potential confounders, maternal CP was associated with increased risk of preterm birth (12.9% vs 4.9%; adjusted odds ratio [aOR] 2.8, 95% CI 2.3‐3.5), cesarean delivery (aOR 1.9, 95% CI 1.6‐2.2), induced delivery (aOR 1.4, 95% CI 1.1‐1.6), low 5‐min Apgar score (aOR 1.8, 95% CI 1.1‐2.9) and small of gestational age birth (aOR 1.6, 95% CI 1.2‐2.3). We found no increased risk of large for gestational age or stillbirth.Conclusions: Women with CP are at increased risk of preterm birth and other adverse pregnancy outcomes, suggesting that they deserve extra surveillance during antenatal care. Further studies, with information on type of CP and gross motor function, are warranted to better understand the association between CP and pregnancy outcome.
- 18 November 2019
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 99 (4) , 518-524
Pregnancy outcome in women with cerebral palsy: A nationwide population‐based cohort study
Introduction: Cerebral palsy (CP) is a lifelong disorder with a high rate of comorbidities and complications. We hypothesized that women with CP are at increased risk of adverse pregnancy outcome.Material and methods: In this nationwide population‐based cohort study 1997‐2011, we examined the outcome of 770 births in women with CP vs 1 247 408 births in women without a CP diagnosis using the Swedish Medical Birth Register. We used unconditional logistic regression, adjusting for maternal age, smoking, parity, year of birth and epilepsy, to calculate adjusted odds ratios for adverse pregnancy outcome. Main adverse outcome was preterm birth. Secondary outcomes were cesarean section, induction of labor, low 5‐min Apgar score, small for gestational age, large for gestational age, and stillbirth.Results: After adjusting for potential confounders, maternal CP was associated with increased risk of preterm birth (12.9% vs 4.9%; adjusted odds ratio [aOR] 2.8, 95% CI 2.3‐3.5), cesarean delivery (aOR 1.9, 95% CI 1.6‐2.2), induced delivery (aOR 1.4, 95% CI 1.1‐1.6), low 5‐min Apgar score (aOR 1.8, 95% CI 1.1‐2.9) and small of gestational age birth (aOR 1.6, 95% CI 1.2‐2.3). We found no increased risk of large for gestational age or stillbirth.Conclusions: Women with CP are at increased risk of preterm birth and other adverse pregnancy outcomes, suggesting that they deserve extra surveillance during antenatal care. Further studies, with information on type of CP and gross motor function, are warranted to better understand the association between CP and pregnancy outcome.
- Open Access
- 1 November 2018
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 10, 1817-1826
Pregnancy outcomes in women with autism: a nationwide population-based cohort study
Background: The consequences of autism in pregnancy outcomes have not been explored before, although it is of crucial importance because of the frequent comorbidities and medication in this group of women. Objectives: To estimate the risk of adverse pregnancy outcomes in women diagnosed with autism. Design: Nationwide population-based cohort study. Setting: Sweden. Participants: Singleton births identified in the Swedish Medical Birth Registry, 2006–2014. A total of 2,198 births to women diagnosed with autism registered in the Swedish National Patient Registry were compared to 877,742 singleton births to women without such a diagnosis. Main outcome and measures: Preterm delivery. Secondary measures were cesarean delivery (emergency and elective), Apgar score Results: Women with autism were at increased risk of preterm birth (OR=1.30; 95% CI=1.10–1.54), especially medically indicated preterm birth (OR=1.41; 95% CI=1.08–1.82), but not with spontaneous preterm birth. Maternal autism was also associated with an increased risk of elective cesarean delivery (OR=1.44; 95% CI=1.25–1.66) and preeclampsia (OR=1.34; 95% CI=1.08–1.66), but not with emergency cesarean delivery, low Apgar score (Conclusion and relevance: Maternal autism is associated with preterm birth, likely due to an increased frequency of medically indicated preterm births, but also with other adverse pregnancy outcomes, suggesting a need for extra surveillance during prenatal care.
- 1 November 2018
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 10, 1817-1826
Open AccessPregnancy outcomes in women with autism: a nationwide population-based cohort study
Background: The consequences of autism in pregnancy outcomes have not been explored before, although it is of crucial importance because of the frequent comorbidities and medication in this group of women. Objectives: To estimate the risk of adverse pregnancy outcomes in women diagnosed with autism. Design: Nationwide population-based cohort study. Setting: Sweden. Participants: Singleton births identified in the Swedish Medical Birth Registry, 2006–2014. A total of 2,198 births to women diagnosed with autism registered in the Swedish National Patient Registry were compared to 877,742 singleton births to women without such a diagnosis. Main outcome and measures: Preterm delivery. Secondary measures were cesarean delivery (emergency and elective), Apgar score Results: Women with autism were at increased risk of preterm birth (OR=1.30; 95% CI=1.10–1.54), especially medically indicated preterm birth (OR=1.41; 95% CI=1.08–1.82), but not with spontaneous preterm birth. Maternal autism was also associated with an increased risk of elective cesarean delivery (OR=1.44; 95% CI=1.25–1.66) and preeclampsia (OR=1.34; 95% CI=1.08–1.66), but not with emergency cesarean delivery, low Apgar score (Conclusion and relevance: Maternal autism is associated with preterm birth, likely due to an increased frequency of medically indicated preterm births, but also with other adverse pregnancy outcomes, suggesting a need for extra surveillance during prenatal care.